Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10036000HBVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS10031972HBVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS30010023HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS30000259HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS30073897HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS30073898HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS30073899HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS30073900HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS30073901HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS30073902HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TCGA Plot Options
Drug Information
GeneF8
DrugBank IDDB00100
Drug NameCoagulation Factor IX (Recombinant)
Target IDBE0000016
UniProt IDP00451
Regulation Typecofactor
PubMed IDs11150722; 12719776; 12826528; 14598591; 16476097; 659613
CitationsNeels JG, Bovenschen N, van Zonneveld AJ, Lenting PJ: Interaction between factor VIII and LDL receptor-related protein. Modulation of coagulation? Trends Cardiovasc Med. 2000 Jan;10(1):8-14.@@Carr ME Jr, Martin EJ, Kuhn JG, Seremetis SV: Effects of recombinant factor VIIa on platelet function and clot structure in blood with deficient prothrombin conversion. Thromb Haemost. 2003 May;89(5):803-11.@@Federici AB: The factor VIII/von Willebrand factor complex: basic and clinical issues. Haematologica. 2003 Jun;88(6):EREP02.@@Kalashnikova LA, Berkovskii AL, Dobrynina LA, Sergeeva EV, Kozlov AA, Aleksandrova EN, Nasonov EL: [Clotting factor VIII in Sneddon syndrome]. Klin Med (Mosk). 2003;81(9):42-5.@@Johansen RF, Sorensen B, Ingerslev J: Acquired haemophilia: dynamic whole blood coagulation utilized to guide haemostatic therapy. Haemophilia. 2006 Mar;12(2):190-7.@@Di Scipio RG, Kurachi K, Davie EW: Activation of human factor IX (Christmas factor). J Clin Invest. 1978 Jun;61(6):1528-38.
GroupsApproved; Investigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKBPA164744952
ChEMBL